U.S. Markets closed

Biostar Pharmaceuticals, Inc. (BSPM)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.35-0.07 (-4.93%)
At close: 3:59PM EDT
People also watch
SPUCLRBHMNYEBIOKONE
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue2,384.49227,129.60961,416.587
Cost of Revenue1,469.31816,025.54431,140.225
Gross Profit915.17411,104.06530,276.362
Operating Expenses
Research Development1,144.0444,020.9092,766.162
Selling General and Administrative3,600.87813,288.0826,205.138
Non Recurring-265.48617,552.642,617.757
Others---
Total Operating Expenses---
Operating Income or Loss-3,564.262-23,757.564-1,312.695
Income from Continuing Operations
Total Other Income/Expenses Net725.126248.4443,001.873
Earnings Before Interest and Taxes-2,839.136-23,509.121,689.178
Interest Expense206.195283.596154.547
Income Before Tax-3,045.331-23,792.7161,534.631
Income Tax Expense2,653.0541,319.846-3,313.581
Minority Interest---
Net Income From Continuing Ops-5,698.385-25,112.5624,848.212
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-5,698.385-25,112.5624,848.212
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-5,698.385-25,112.5624,848.212